Global Markets for Peripheral Vascular Stent Products
Order individually or subscribe to Medtech Pro and get a complete intel platform.
Overview
The global market for peripheral vascular stents, which was valued at $1.1 billion in 2013, has entered into a dynamic phase which will be characterized by the rising prevalence of peripheral artery disease (PAD), growing availability in key regional markets, and the adoption of potentially competitive products, such as drug-coated balloons (DCBs). In the U.S., where DCBs became commercially available in October 2014, the use of stents will continue to be driven by the availability of products that enable treatment for different types of lesions and have indications specific to the target anatomy-e.g., the carotid, femoral, popliteal, iliac, and renal arteries. This should contribute to growing use in patients at high risk for problems following surgical intervention as well as those with applicable lesion profiles. In Europe, where cost-containment efforts are expected to generate price erosion, demographic factors and the use of stents as part of a multi-modal treatment strategy will fuel revenue gains. And in countries in the Asia-Pacific region and the rest of the world, growth will be driven by greater access to care and rising access in underpenetrated markets.
Critical Issues Covered in this Report:
• The competitive landscape for these devices in the U.S. and international markets;
• Quantitative factors including units, pricing, and product sales; and
• Procedure volumes as well as other key infrastructure and market metrics.
Companies Covered
Abbott Vascular (Abbott)Bard Peripheral Vascular (C.R. Bard)
Boston Scientific
Cook Medical (Cook Group)
Cordis Corporation (Johnson & Johnson)
ev3/Covidien
Medtronic
W.L. Gore and Associates
Table of Contents
1. EXECUTIVE SUMMARY 1.1 The Global Market by Product Type 1.2 The Global Market by Region 1.3 Competitive Analysis Exhibit 1-1: The Global Market Forecast for Peripheral Vascular Stent Products from 2012-2019 Exhibit 1-2: The Global Market Forecast for Peripheral Vascular Stents by Product Type from 2012-2019 Exhibit 1-3: The Global Market Forecast for Peripheral Vascular Stents by Region from 2012-2019 Exhibit 1-4: Global Supplier Shares in 2012 and 2013 2. OVERVIEW 2.1 The Circulatory System 2.2 Vascular Anatomy and Physiology 2.2.1 Peripheral Arteries 2.2.2 Coronary Arteries 2.2.3 Arteries of the Head and Neck 2.3 Vessel Tissues and Structures 2.4 Peripheral Vascular Disease 2.5 Prevalence of PAD by Region 2.5.1 The United States 2.5.2 Europe 2.5.3 Asia-Pacific and the Rest of the World Exhibit 2-1: Overview of the Circulatory System Exhibit 2-2: Major Arteries in the Cardiovascular System Exhibit 2-3: Types and Functions of the Blood Vessels Exhibit 2-4: Peripheral Arteries and Arteries of the Lower Extremity Exhibit 2-5: Arteries of the Hand, Including the Radial Artery Exhibit 2-6: Arteries of the Head and Neck Exhibit 2-7: Anatomy of the Arteries and Veins Exhibit 2-8: Prevalence of Peripheral Artery Disease in the U.S. Global Markets for Peripheral Vascular Stent Products in 2014 Exhibit 2-9: Prevalence of Peripheral Artery Disease in Europe Exhibit 2-10: Prevalence of Peripheral Artery Disease in AP & ROW Countries 3. PERIPHERAL VASCULAR STENT PRODUCTS 3.1 Carotid Artery Stents 3.2 Femoropopliteal Stents 3.3 Iliac Artery Stents 3.4 Renal Artery Stents Exhibit 3-1: Types of Peripheral Vascular Stents Exhibit 3-2: Selected Recent Studies of Carotid Artery Stenting Exhibit 3-3: Carotid Artery Stents: Selected Products and Suppliers in 2014 Exhibit 3-4: Selected Recent Studies of Femoropopliteal Artery Stenting Exhibit 3-5: Femoropopliteal Stents: Selected Products and Suppliers in 2014 Exhibit 3-6: Selected Recent Studies of Iliac Artery Stenting Exhibit 3-7: Iliac Artery Stents: Selected Products and Suppliers in 2014 Exhibit 3-8: Selected Recent Studies of Renal Artery Stenting Exhibit 3-9: Renal Artery Stents: Selected Products and Suppliers in 2014 4. PROCEDURE FORECASTS & MARKET ANALYSIS 4.1 The Global Market Forecast for Peripheral Vascular Stent Products 4.2 The Market by Region 4.2.1 The United States 4.2.2 Europe 4.2.3 Asia-Pacific and the Rest-of-the-World Exhibit 4-1: The Global Market Forecast for Peripheral Vascular Stent Products from 2012-2019 Exhibit 4-2: The Global Market Forecast for Peripheral Vascular Stents by Product Type from 2012-2019 Exhibit 4-3: The Global Market Forecast for Peripheral Vascular Stents by Region from 2012-2019 Exhibit 4-4: The U.S. Market Forecast for Peripheral Vascular Stent Products from 2012-2019 Exhibit 4-5: The U.S. Market Forecast for Peripheral Vascular Stents by Product Type from 2012-2019 Exhibit 4-6: The U.S. Market Forecast for Carotid Artery Stents from 2012-2019 4-10 Exhibit 4-7: The U.S. Market Forecast for Femoropopliteal Artery Stents from 2012-2019 Exhibit 4-8: The U.S. Market Forecast for Iliac Artery Stents from 2012-2019 Exhibit 4-9: The U.S. Market Forecast for Renal Artery Stents from 2012-2019 Exhibit 4-10: U.S. Supplier Shares in 2012 and 2013 Exhibit 4-11: The European Market Forecast for Peripheral Vascular Stent Products from 2012-2019 Exhibit 4-12: The European Market Forecast for Peripheral Vascular Stents by Product Type from 2012-2019 Exhibit 4-13: The European Market Forecast for Carotid Artery Stents from 2012-2019 Exhibit 4-14: The European Market Forecast for Femoropopliteal Artery Stents from 2012-2019 Exhibit 4-15: The European Market Forecast for Iliac Artery Stents from 2012-2019 Exhibit 4-16: The European Market Forecast for Renal Artery Stents from 2012-2019 Exhibit 4-17: The AP & ROW Market Forecast for Peripheral Vascular Stent Products from 2012-2019 Exhibit 4-18: The AP & ROW Market Forecast for Peripheral Vascular Stents by Product Type from 2012-2019 Exhibit 4-19: The AP & ROW Market Forecast for Carotid Artery Stents from 2012-2019 Exhibit 4-20: The AP & ROW Market Forecast for Femoropopliteal Artery Stents from 2012-2019 Exhibit 4-21: The AP & ROW Market Forecast for Iliac Artery Stents from 2012-2019 Exhibit 4-22: The AP & ROW Market Forecast for Renal Artery Stents from 2012-2019 Exhibit 4-23: OUS Supplier Shares in 2012 and 2013 5. COMPANY PROFILES 5.1 Abbott Vascular (Abbott) 5.2 Bard Peripheral Vascular (C.R. Bard) 5.3 Boston Scientific 5.4 Cook Medical (Cook Group) 5.5 Cordis Corporation (Johnson & Johnson) 5.6 Covidien 5.7 Medtronic 5.8 W.L. Gore and Associates
